ERBB4 inhibitors and methods of use thereof

    公开(公告)号:US10045990B2

    公开(公告)日:2018-08-14

    申请号:US15555241

    申请日:2016-03-02

    IPC分类号: A61K31/519 A61K31/517

    摘要: Disclosed herein are methods of treating diseases that exhibit over-activation of the ERBB4 pathway, such as breast cancer and lung cancer. The method comprises administering to a subject having a disease that exhibits over-activation of the ERBB4 pathway and a gene expression profile consistent with an ERBB4-sensitive profile a therapeutically effective amount of an ERBB4 inhibitor, wherein the disease is effectively treated. Gene expression profiles of ERBB4-sensitive cells and microarrays suitable for protein-tyrosine kinases are also provided.